ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975

Three researchers share Paul Marks Prize.

November 11, 2005

Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected

October 1, 1976

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures

June 5, 1987